Smart Supraglottic Airway Device System

A novel system integrating a supraglottic airway device with AI, IoT, blockchain, and advanced materials to minimize contamination exposure, optimize performance, and ensure sterility tracking.

The original supraglottic airway device patent addressed the need for a medical airway device that reduces potential contamination exposure to patients and medical professionals. However, it lacked real-time monitoring and control capabilities, AI-driven optimization, IoT connectivity, and advanced materials for enhanced performance and sterility. The new inventive concept solves these limitations by introducing a synergistic combination of these technologies.

The Smart Supraglottic Airway Device System comprises a sensor-integrated coupler device that detects contamination exposure and transmits real-time data to a remote monitoring station via a wireless communication module. An AI-powered algorithm analyzes the data and adjusts the suction operation to minimize contamination exposure. The system also features IoT connectivity, enabling real-time data transmission to a cloud-based server and mobile application notifications. Additionally, the device incorporates a self-cleaning surface coating and biocompatible material to reduce bacterial adhesion and patient discomfort. A blockchain-based system tracks and verifies the device's sterility, ensuring a secure and transparent record of usage and sterilization history.

The new claims introduce a novel combination of AI, IoT, blockchain, and advanced materials that significantly enhances the original supraglottic airway device's functionality and performance. The integration of these technologies provides a non-obvious solution to the problem of contamination exposure and sterility tracking in medical airway devices.

Alternative embodiments of the Smart Supraglottic Airway Device System could include varying sensor types, AI algorithm modifications, and different IoT connectivity protocols. Variations may also include the use of other advanced materials, such as antimicrobial coatings or nanomaterials, to further enhance the device's performance and sterility.

The Smart Supraglottic Airway Device System has significant commercial potential in the medical device industry, particularly in the fields of anesthesiology, critical care, and emergency medicine. The system's ability to minimize contamination exposure, optimize performance, and ensure sterility tracking addresses a critical need in the market, providing a competitive advantage for manufacturers and healthcare providers.